Suven presenting positive Pre-clinical, Phase-1 clinical data at Neuroscience 2018
Suven Life Sciences (Suven) is participating and presenting positive Pre-clinical and Phase-1 clinical data of several advanced molecules from their portfolio of new chemical entities (NCEs) and the…

